ÂÜÀòÂÒÂ×

The Research and Development team at Minoryx Therapeutics is dedicated to discovering and developing innovative treatments for rare pediatric neurometabolic diseases of genetic origin. They focus on advancing small molecule drugs, particularly pharmacological chaperones, and explore drug repositioning strategies to rapidly bring effective therapies to patients. The team consists of R&D managers and senior scientists who drive these projects forward through rigorous scientific research and project management.